Treating CNS sarcoidosis with infliximab and mycophenolate mofetil James Corbett Clinical Trials Report 01 August 2009 Pages: 339 - 340
Alemtuzumab versus interferon beta-1a in early multiple sclerosis Dennis BourdetteVijayshree Yadav Clinical Trials Report 01 August 2009 Pages: 341 - 342
Update on amyloid imaging: From healthy aging to Alzheimer’s disease David A. WolkWilliam E. Klunk OriginalPaper 01 August 2009 Pages: 345 - 352
TDP-43 and frontotemporal dementia William T. HuMurray Grossman OriginalPaper 01 August 2009 Pages: 353 - 358
Immunologically mediated dementias Michael H. RosenbloomSallie SmithMichael D. Geschwind OriginalPaper 01 August 2009 Pages: 359 - 367
An update on treatment and prevention strategies for Alzheimer’s disease Judith NeugroschlMary Sano OriginalPaper 01 August 2009 Pages: 368 - 376
Neuro-ophthalmology and the anti-GQ1b antibody syndromes Robert F. Saul OriginalPaper 01 August 2009 Pages: 379 - 383
Current pharmacologic testing for horner syndrome Mansoor MughalReid Longmuir OriginalPaper 01 August 2009 Pages: 384 - 389
Selected lid problems in neurologic practice Gregory S. KosmorskyAlyssa Fiddler OriginalPaper 01 August 2009 Pages: 390 - 395
Gray matter pathology and multiple sclerosis Christiane WegnerChristine Stadelmann OriginalPaper 01 August 2009 Pages: 399 - 404
Epstein-barr virus in multiple sclerosis Bridget A. Bagert OriginalPaper 01 August 2009 Pages: 405 - 410
Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis Kimmy G. SuGary BankerMichael Forte OriginalPaper 01 August 2009 Pages: 411 - 417